InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by INGRAM DOUGLAS S, Chairman & CEO. Director active across 1 companies, notably Sarepta Therapeutics, Inc.. In total, 4 disclosures have been recorded. Total volume traded: €3.5m. The latest transaction was filed on 17 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€2m25,026 shares@ €70.61159.5% of flow
Common Stock
SEC:0001209191-21-065246·
Ideal exit: 14 Aug 2022 (T+270)
€2m25,026 shares@ €70.6110.078% mcap29.8% of flow
Common Stock
SEC:0001209191-21-065246:0·
Ideal exit: 14 Aug 2022 (T+270)
€1m17,812 shares@ €67.391340.5% of flow
Common Stock
SEC:0001209191-21-043582·
€1m17,812 shares@ €67.39130.053% mcap20.2% of flow
Common Stock
SEC:0001209191-21-043582:0·
4 of 4 declarations
About INGRAM DOUGLAS S
Douglas S. Ingram is the President and CEO of Sarepta Therapeutics, Inc. He leads the company with a strategic vision, overseeing operations and business development. His leadership is essential for innovation and growth at Sarepta Therapeutics, Inc.
